Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
—
Company details
Market cap
~$9B
P/E ratio
~10×
Div yield
~1.0%
Revenue
~$11.2B
Rev. growth
+6%
Free cash flow
~$0.9B
Total debt
~$9.5B
Credit rating
BBB-
In plain English
Baxter is the company behind the everyday machinery of a hospital: the IV bags and fluids that hang from nearly every bedside, the infusion pumps that dose medicine, the smart hospital beds and patient monitors (from its Hillrom buy), and a portfolio of injectable and inhaled drugs. After shedding its kidney-care arm (Vantive, sold to Carlyle in 2025) and its drug-contract-manufacturing unit, it is a slimmed-down, debt-paying medtech focused on the products that keep wards running.
In simple terms
What Baxter International really sells
Baxter is the company behind the everyday machinery of a hospital: the IV bags and fluids that hang from nearly every bedside, the infusion pumps that dose medicine, the smart hospital beds and patient monitors (from its Hillrom buy), and a portfolio of injectable and inhaled drugs. After shedding its kidney-care arm (Vantive, sold to Carlyle in 2025) and its drug-contract-manufacturing unit, it is a slimmed-down, debt-paying medtech focused on the products that keep wards running.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.